SCHEMBL7721640

SCHEMBL7721640

CCCc1ccnc2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCNCC4)ccc3OCC)nc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.69
PDE3B Q13370 3/20 0.59
PDE3A Q14432 3/20 0.59
PDE1A P54750 3/20 0.59
PDE1B Q01064 3/20 0.59
PDE1C Q14123 3/20 0.59
PDE4B Q07343 2/20 0.59
PDE2A O00408 1/20 0.59
ABCC4 O15439 1/20 0.59
ABCC5 O15440 1/20 0.59
PDE6D O43924 1/20 0.59
PDE8A O60658 1/20 0.59
PDE9A O76083 1/20 0.59
ABCB11 O95342 1/20 0.59
CYP3A4 P08684 1/20 0.59
HTR1A P08908 1/20 0.59
PDE6A P16499 1/20 0.59
PDE6G P18545 1/20 0.59
PDE4A P27815 1/20 0.59
ADORA2A P29274 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8149898 0.92 PDE5A (0.70) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL3840503 0.88 PDE5A (0.72) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL3842010 0.87 PDE5A (0.63) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL5596744 0.86 PDE5A (0.62) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL7725915 0.86 PDE5A (0.62) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL7721206 0.83 KDM4E (0.66) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL1141 0.82 PDE5A (1.00) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL30199797 0.82 PDE5A (1.00) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL8801494 0.80 PDE5A (0.58) PDE5APDE1APDE2APDE9APDE4A
SCHEMBL9021637 0.80 PDE5A (0.86) PDE5APDE3BPDE3APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391885-B1 CONTROLLING APOPTOSIS IN AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2002-05-21 US disclosed
US-6060477-A Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives CELL PATHWAYS, INC. (US) 2000-05-09 US disclosed
EP-0656898-B1 PYRIDOPYRIMIDINONE ANTIANGINAL AGENTS PFIZER LTD (GB) 1997-01-22 EP disclosed
US-5591742-A TREATMENT OF ANGINA, HYPERTENSION, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS PFIZER INC. (US) 1997-01-07 US disclosed